Although both Treg and Th17 cells exert a diverse set of cancer-related functions (Figs. 3 and 4), these CD4+ T cell subsets may have opposing prognostic values in lung cancer, with a higher ratio of Tregs to Th17s correlating with more aggressive and advanced-staged malignancies [125, 126]. The gene discussed is CD4; the disease is cancer.